drugset / Trial / NCT00833521

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

NCT00833521

Phase 1 Completed 38 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the relative bioavailability of Zolpidem tartrate 10 mg tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA Pharmaceuticals USA) with that of AMBIEN® tablets(G.D. Searle \& Co.) in healthy, adult, non-smoking subjects under fasting conditions.

Timeline

Start
2002-02
Primary completion
2002-02
Completion
2002-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zolpidem Small molecule 10 mg

Indications

No indication recorded.